Purchase Order 75N95021P00654
Award Date
9/23/21
Potential Completion Date
10/29/21
Potential Value
$100K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Enamine US Inc.
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Ukraine
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $21,296 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services (HHS), to Enamine US Inc. for a set of compounds/molecules. The contract has no set-aside designation. Enamine US Inc. is a for-profit organization that provides chemical compounds and research services to support pharmaceutical, biotechnology, and other life science companies and research organizations....
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, to Enamine US Inc. for a pharmacokinetic study in mice compounds. The award amount is $14,550.00 and the period of performance ends on August 18, 2025. This contract was not set aside for any small business category. Enamine US Inc. is a for-profit organization that provides a range of chemical products and...
This is a $235,092.20 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to MedChemExpress LLC, a New Jersey-based provider of biochemicals and other life science research materials. The contract is for the delivery of a custom chemical library of 84 items to the National Center for Advancing Translational Sciences (NCATS) to support its COVID-19 research. No set-aside designation was used. As a...
This firm fixed price purchase order awards Enamine LTD $230,323.60 to provide the National Center for Advancing Translational Sciences two general GPCR libraries totaling 27,000 compounds at $5.20 per compound. The libraries will support the National Institutes of Health's National Institute on Drug Abuse in identifying and developing novel small molecule leads against human disease targets through screening of thousands of compounds. One library will contain a minimum of 25,000 general GPCR...
This is a firm fixed price purchase order contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the U.S. Department of Health and Human Services (HHS), to Enamine LTD, a limited liability company based in Cincinnati, Ohio. The contract is for LC-MS/MS analysis services to support the NIAAA's biomedical research programs. The total ceiling value of the contract is $14,964.80 and the ultimate completion date is November 22, 2023. The contract does not...
This $113,163 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences to MedChemExpress LLC, a New Jersey-based provider of biochemicals, bioactive compounds, peptides, and other life science research materials. The contract is for the delivery of 75 chemical compounds to support ongoing COVID-19 research. The award was made via a purchase order under a non-competitive combined...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $19,800 firm fixed price purchase order to Karebay Biochem Inc., a for-profit small business, to synthesize 200 grams of compound NCGC00413972. This order supports NIH's biomedical research programs, particularly in the areas of drug discovery and infectious disease. Karebay Biochem has received multiple prior purchase orders from NIH entities to...
This is a $17,130.20 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Sigma-Aldrich, Inc. to provide a COVID-19 clinical stage drug library. The contract has no set-aside designation and is scheduled for completion by December 31, 2021. Sigma-Aldrich, a foreign-owned, for-profit life science company, has a wide range of federal contract vehicles...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Chembridge Corp, a small business, for a chemical compound library of 50,000 compounds at 0.25 micromoles each, for a total potential value of $44,000.00. The contract was awarded under Simplified Acquisition Procedures as a total small business set-aside. The chemical compounds are being acquired for use by the...
This is a $96,900.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for a chemical library of 2,550 small molecule compounds distributed across specified chemical scaffolds. The contract has an ultimate completion date of October 15, 2019. The requirement was originally posted as an open solicitation and there was no set-aside designation. The chemical library will be used by NIDA's...